Encap Drug Delivery receives patent approval for DuoCap capsule system
Encap Drug Delivery receives patent approval for DuoCap capsule system
Press releases, news and updates.
Encap Drug Delivery receives patent approval for DuoCap capsule system
Encap, the global drug delivery solutions provider, today announced the appointment of Jane Fraser as Research and Development Director
Leading academic and industrial experts within oral drug delivery present series of talks to attendees
Alfa to promote Encap services alongside Gattefosse’s range of lipid excipients
Encap Drug Delivery and The School of Pharmacy agree colonic drug delivery licensing deal
The last 12 months have been a very busy and exciting time for Encap Drug Delivery, including doubling our facility size and gaining FDA approval. The News Capsule has been designed to share some of the company’s recent highlights and developments with you.
Encap Drug Delivery and Probac AB announce a collaboration agreement for the development of an oral probiotic for the treatment of antibiotic associated diarrhoea.
Encap Drug Delivery announces recent successful MHRA audit results.
2009 marks Encap Drug Delivery’s 20th anniversary.
Encap’s novel ABUSOLVE technology successfully used to develop new abuse resistant medication.
Encap Drug Delivery has received official notification from the US Food and Drug Administration (FDA) that its facility is now classified as acceptable based on the facility inspection which took place earlier this year.
2008 West Lothian Chamber of Commerce Business Excellence Innovation Award.
Encap are delighted to announce that Nicola Sturgeon, Deputy First Minister and Cabinet Secretary for Health and Wellbeing, has officially opened the second and final phase of our new £3 million expansion, on 23rd September 2008.
Encap, the international drug delivery solutions provider, announced today the appointment of Robbie Stewart as Sales Director.
Encap, the international drug delivery solutions provider, today announced that it has signed an agreement with Thermal Transfer Limited (TTL) to build a £3 million state-of-the-art pharmaceutical development and manufacturing facility in Livingston, Scotland.
Encap, the international drug delivery solutions provider, has strengthened its Board of Directors and appointed Dr Stephen Brown as R&D Director with immediate effect.
Encap, the international drug delivery solutions provider, announced today that it has signed a Head of Terms with Kenmore Capital Oakbank Ltd.
Copyright © Encap 2010
Web design: Net Resources